Wong2017_Article_HypogonadismInTheHIV-InfectedM.pdf (605.93 kB)
Download file

Hypogonadism in the HIV-Infected Man

Download (605.93 kB)
journal contribution
posted on 12.09.2019, 13:46 by Nicholas Wong, Miles Levy, Iain Stephenson
Low testosterone levels are frequently observed among men with treated and untreated HIV infection. However, the interpretations of biochemical measurements of testicular function are challenging and need to be considered in the context of the clinical presentation and scenario. The distinction between primary and secondary hypogonadism and determination of the underlying clinical pathophysiology are not always straightforward. Early recognition of clinical hypogonadism and appropriate treatment may improve clinical outcomes and quality of life for affected individuals. A principal aim of testosterone replacement is to maintain serum testosterone concentrations in the normal physiological range and should be considered in clinically symptomatic patients.

History

Citation

Current Treatment Options in Infectious Diseases, 2017, 9 (1), pp. 104-116

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation

Version

VoR (Version of Record)

Published in

Current Treatment Options in Infectious Diseases

Publisher

Springer (part of Springer Nature)

eissn

1534-6250

Copyright date

2017

Available date

12/09/2019

Publisher version

https://link.springer.com/article/10.1007/s40506-017-0110-3

Language

en